The DOI matches its Crossref record; 366 of the 371 references it cites were found in a registry or an index.
EASL Clinical Practice Guidelines: Drug-induced liver injury
Abstract
Idiosyncratic (unpredictable) drug-induced liver injury is one of the most challenging liver disorders faced by hepatologists, because of the myriad of drugs used in clinical practice, available herbs and dietary supplements with hepatotoxic potential, the ability of the condition to present with a variety of clinical and pathological phenotypes and the current absence of specific biomarkers. This makes the diagnosis of drug-induced liver injury an uncertain process, requiring a high degree of awareness of the condition and the careful exclusion of alternative aetiologies of liver disease. Idiosyncratic hepatotoxicity can be severe, leading to a particularly serious variety of acute liver failure for which no effective therapy has yet been developed. These Clinical Practice Guidelines summarize the available evidence on risk factors, diagnosis, management and risk minimization strategies for drug-induced liver jury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-induced liver injury (DILI) is an uncommon adverse reaction to drugs, and other chemicals, including herbal and dietary supplements (HDS).”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [2]
In the citing paper
“The vast majority of cases of DILI occur at therapeutic doses in a small proportion of individuals exposed to the drug, representing an idiosyncratic reaction, and therefore unpredictable based on the drug's mechanism of action and related to the uniqueness of the individual [1,2].”
From DILI Differences and Similarities between the US and Europe (2026) · cites this paper as [2]
In the citing paper
“In pediatric medicine, DILI is a rare clinical situation. However, it has high morbidity and mortality, and it is one of the most common causes of acute liver failure. Furthermore, its diagnosis is clinically challenging due to its low incidence and phenotypic variability [6,7,8].”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [7]
In the citing paper
“The lack of a reliable diagnostic biomarker and evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“The lack of reliable diagnostic biomarkers and an evidence-based treatment paradigm has resulted in limited guidance on how to manage this aspect of DILI.2,25–27”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“However, drug rechallenge in DILI cases is potentially dangerous2,75 and is associated with risk of death or requirement for liver transplant.”
From Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report (2023) · cites this paper as [2]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“High TBil and ALP levels in the second month after an acute DILI episode and the biochemical nonresolution-6 model may help predict the risk of chronic injury and delayed recovery [26,72].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“Although there are some ambiguities regarding how to score certain sections as well as suboptimal reliability, RUCAM can provide systematic and framed guidance for the assessment of patients with suspected DILI and is the most widely used tool [26,27,51,59].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
In the citing paper
“Its potential value in confirming or excluding hepatocellular injury in cases of elevated ALT levels from a suspected extrahepatic origin (e.g., muscle) has been evaluated [26,175].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [26]
Citations
Cites
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
El-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Acetaminophen‐induced acute liver failure
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., REISCH, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,913
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Flagged first, then by citations
5 of the 371 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Nicoletti, 2017, Genome-wide association study (GWAS) to identify genetic risk factors that increase susceptibility to antituberculosis drug-induced liver injury (ATDILI) [Abstract], Hepatology, 66, A-25
- Lim, 2008, Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review, Neurol Asia, 13, 15
- US Food & Drug Administration, 2017, Drugs
- Sanjuan-Jimenez, 2017, Prevalence of hepatitis E markers in Spanish patients with suspected drug-induced liver injury [abstract], Hepatology, 66, 423A
- Fernández-Castañer, 2008, An analysis of the causes, characteristics, and consequences of reexposure to a drug or compound responsible for a hepatotoxicity event, Rev Esp Enfermedades Dig, 100, 278
Cited by
Sorted by citations
Items 901–1,000 of 1,278
Zhang, Q., Lu, C., Wang, H., Wu, S., Jiang, L., Li, J., Wu, Z., Tang, B., Yang, B., Liao, S., et al. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2425069 · Cited by 1
Mohammed, F. R., Hummadi, Y. M. K. A. M., & Al-Ezzi, M. I. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e136976 · Cited by 1
Clinicopathological characteristics of autoimmune‑like hepatitis after drug‑induced liver injury
Ikeda, K., Fukui, S., Kobayashi, M., Shimada, Y., Nakazawa, Y., Mizutani, H., Nishiura, Y., Suga, D., Moritani, I., Yamanaka, Y., et al. (2025) · Biomedical Reports · doi:10.3892/br.2025.1953 · Cited by 1
Anabolic androgenic steroid-induced cholestasis
MACEDO, L. B. D., Batista, A. D., Arruda, R. M., Maia, L. G., Liberato, I. R. D. O., Filgueira, N. A., Domingues, A. L. C., & Lopes, E. P. (2025) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.24.05463-9 · Cited by 1
Xiong, Y., Xin, H., Shi, C., Guo, X., Chen, Y., Huang, C., Ma, F., Ge, Y., & Yang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1558054 · Cited by 1
Chen, H., Ding, Y., Wu, M., Xu, Y., Zhao, H., Cheng, X., Jin, C., Wu, D., & Zhang, W. (2025) · Waste and Biomass Valorization · doi:10.1007/s12649-025-03171-w · Cited by 1
Attree, C., Saibil, S. D., Fischer, S. E., & Cunningham, M. E. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-265370 · Cited by 1
Drug‐Induced Liver Failure Following Topical Minoxidil: A Case Report
Premke, K., Kästner, M., Fritzsche, C., Erbersdobler, A., & Loebermann, M. (2025) · Case Reports in Gastrointestinal Medicine · doi:10.1155/crgm/1040092 · Cited by 1
Nurul, S., Wahyuni, R., Djawad, K., Ilyas, F. S., Dewiyanti, W., Rahma, S. N., & Herlina, I. (2020) · Serbian Journal of Dermatology and Venerology · doi:10.2478/sjdv-2020-0009 · Cited by 1
DRESS syndrome and drug-induced liver injury owing to antituberculous treatment
Irabien, M., Blanco, S., & Calderón, Á. J. (2020) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2020.07.011 · Cited by 1
Drug-induced liver injury associated with acenocumarol exposure
Gruz, F., & Anders, M. (2021) · Drugs & Therapy Perspectives · doi:10.1007/s40267-021-00811-8 · Cited by 1
Thurin, N. H. (2019) · theses.fr (ABES) · doi:10.70675/1e40acc6z10ecz4f0bzbef0zfc3521606317 · Cited by 1
Reuben, A. (2020) · Liver Transplantation · doi:10.1002/lt.25853 · Cited by 1
Novel insights into toxic and chronic liver disease
Zoubek, M. E. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210929mz · Cited by 1
Tao, X., Zhao, Y., Chen, L., Zeng, M., Mi, Y., & Xu, L. (2022) · Hepatology · doi:10.1002/hep.32389 · Cited by 1
Letter to the Editor: Fimasartan-Induced Liver Injury and Update on Hepatotoxicity Risks
Lee, J., Chin, S., Kim, S. G., Kim, Y. S., & Yoo, J. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e271 · Cited by 1
DILI Differences and Similarities between the US and Europe
Toro-Ortiz, J. P., Andrade, R. J., & Pinazo-Bandera, J. (2026) · Current Hepatology Reports · doi:10.1007/s11901-026-00733-x
Self-citationAbklärung erhöhter Leberwerte – Update 2019
Peck‐Radosavljevic, M. (2019) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-019-0049-y
Oštećenje jetre uzrokovano lijekovima
Sijamhodžić, R., Roža, N., Debelić, M., & Hrstić, I. (2020) · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
Prise en charge des toxicités hépatiques sous immunothérapie anticancéreuse
Lebossé, F., Bancel, B., Levrero, M., & Merle, P. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.06.011
Drug-Induced Acute and Acute on Chronic Liver Failure
Vijayaraghavan, R., & Sarin, S. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-50983-5_11
Suzuki, S., Taketazu, G., Mukai, T., Sakata, H., & Oki, J. (2020) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0040-1721512
Preventive Health in Liver Disease
Pradhan, F. (2020) · Gastroenterology Open Access Open Journal · doi:10.33169/gastro.goaoj-i-102
Rana, P. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/rana-payal-2020
Is COVID-19-induced liver injury different from other RNA viruses?
Al-Nimer, M. S. M. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i2.108
Embarazo y lesión hepática inducida por medicamentos. Reporte de un caso y revisión de la literatura
Labrador, C., Garzón-Olarte, M., Daza, R., Marín, J. D. M., Lizarazo, J., Molano-Villa, J. C., Marulanda-Gómez, J. C., & T, M. H. R. (2020) · Hepatología · doi:10.52784/27112330.123
A Case of Liver Injury after Exposure to Isopropanol: A Challenging Diagnosis
Santos, D., Nunes, A. L., Matos, A. L., Lai, A. C., Santos, A., & Carvalho, A. D. M. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000510035
Mixed steatohepatitis: more questions than answers (part 2)
Raikhelson, K. L., Александровна, К. Э., & Владимировна, П. Е. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.04.200755
Діденко, В. І., Tatarchuk, О. М., Петішко, О. П., Konenko, I. S., & Меланіч, С. Л. (2021) · GASTROENTEROLOGY · doi:10.22141/2308-2097.55.2.2021.233629
Herbal and Dietary Supplement-Induced Liver Injury: A Nationwide Comparative StudyPreprint
Liu, X., Lai, R., tang, J., Hu, Y., Ding, Y., Aithal, G. P., Andrade, R. J., Watkins, P. B., Shen, T., Jiang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-713611/v1
Self-citationOverview on drug-induced liver injury in Brazil
Bessone, F. (2021) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v12.i5.100
de Lavor, V. A., Maurício, R. B., Taumaturgo, L. D. A., Oliveira, L. D. A., Teixeira, S. L. M., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-1
REPERCUSSÕES SISTÊMICAS DA EXPOSIÇÃO AO DDT
Carneiro, J. A., de Meneses, E. R., de Abreu, M. F. T., de Sá, G. F., Silva, J. V. A., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-4
A IMPORTÂNCIA DO ARMAZENAMENTO HERMÉTICO COMO MÉTODO DE CONSERVAÇÃO EM CEREAIS
Alves, E. D. O., de Lima, T. A. J. R., Silva, J. D. B., Chaves, R. V., & de Freitas, A. C. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-15
SINAIS CLÍNICOS DE LESÃO RENAL AGUDA EM PACIENTES VÍTIMAS DE ACIDENTES OFÍDICOS
Pinho-Schwerman, L., Ramos, F. I., Souza, C. R., Miranda, R. J. D. S., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-12
Oliveira, L. D. A., FILHO, C. G. A. P. D. L., Rabelo, F. C. S., Taumaturgo, L. D. A., PEIXOTO, V. M. T., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-10
ACIDENTES POR TITYUS SERRULATUS: QUADRO CLÍNICO E TERAPÊUTICA
de Sousa, L. A., Alves, B. L. Q., Chaves, L. P. R., Bessa, L. B., Ramos, N. R. C., & Bachur, T. P. R. (2021) · Amplla Editora eBooks · doi:10.51859/amplla.tam726.2121-13
NSAID-induced liver damage with cholestasis
Pereverzev, A. P., Ostroumova, O. D., Головина, О. В., Филиппова, А. В., & Павлеева, Е. Е. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-23-37-48
Estanozolol como anabólico: una causa de hepatotoxicidad
Ramírez, C. Z., & Mejía, M. C. B. (2021) · Medicina UPB · doi:10.18566/medupb.v40n2.a10
Sánchez, F. M. F.-G., Sánchez, F. M. F.-G., Domińguez, E. G., Castillo, C. G., Andres, J. A., Díaz, L. R., & Gil, Y. R. (2021) · Clinical Oncology and Research · doi:10.31487/j.cor.2021.10.03
渡辺, 実., 横内, 正., & 板川, 秀. (1982) · 日本土壌肥料学会講演要旨集
Control de Drosophila suzukii, una plaga de introducción reciente: ¿en dónde estamos?
Ambert, R. G. I. (2013) · Phytoma España: La revista profesional de sanidad vegetal
Drugs and Toxins Affecting Liver Vessels
Elkrief, L., & Rubbia‐Brandt, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-82988-9_21
Şanlıurfa Yöresi İntoksikasyon Olguları ve Karaciğer Toksisitesinin Değerlendirilmesi
SARİ, S., & UYANIKOĞLU, A. (2021) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.931668
Lin, Y., Xu, M., Yi, W., Sun, F., Zeng, Z., Bi, X., Yang, L., Zhang, L., Li, M., & Xie, Y. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.119328
Marjot, T., Ambrose, T., & McGregor, C. (2021) · Oxford University Press eBooks · doi:10.1093/oso/9780198834373.003.0008
Sinha, A., Neema, S., Manrai, M., Vasudevan, B., & Radhakrishnan, S. (2021) · Indian Journal of Drugs in Dermatology · doi:10.4103/ijdd.ijdd_53_20
Vedolizumab-induced cholestatic liver injury
Rojas-Feria, M., Rodríguez-Fernández, M., Castro‐Fernández, M., & García, E. S. (2022) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2020.11.010
Raschi, E., & Caraceni, P. (2022) · Hepatology · doi:10.1002/hep.32407
Oscanoa, T. J., Julca, D. I., Lapeyre-Rivera, A., Jiménez-Pelayo, A., Julón-Buitrón, J., Limache-Canaza, L., Juárez-Pérez, E., Alvarado, J. J., Londoñe-Sullca, R., Liñer-Mendoza, C., et al. (2022) · Boletín de la Sociedad Peruana de Medicina Interna/Revista de la Sociedad Peruana de Medicina Interna · doi:10.36393/spmi.v35i1.649
Putra, P. A., & Suryana, K. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20221096
Review of Liver Enzymes Abnormalities in Patients with SARS-CoV-2 Infection
Tameemi, W. F. A., & Al-Sharqi, A. H. M. M. (2022) · Advanced Biomedicine · doi:10.54730/abm.2022.040202
Pohodenko-Chudakova, I. O., Максимович, Е. В., & Kuznetsov, Y. O. (2021) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2021-2-160-320-323
Jüngst, C., & Kullak-Ublick, G. A. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23847-5.00049-1
Self-citationChronic autoimmune hepatitis triggered by olmesartan
Mínguez, D. R., García, M. L. G., & Fernández‐Rodríguez, C. (2020) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2020.03.013
DRESS syndrome and drug-induced liver injury owing to antituberculous treatment
Irabien, M., Blanco, S., & Calderón, Á. J. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2020.07.016
Alm, M., Andresen, V., Ell, C., Fibbe, C., Fischbach, W., Keller, J., Kipp, P. F., May, A., Miehlke, S., Porschen, R., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-21252-9.00011-0
Decreasing the SGPT level of male wistar rats induced by gentamicin with purslane ethanol extract
Saptaningtyas, R., Rahajoe, T., & Nuroini, F. (2021) · Jurnal Teknologi Laboratorium · doi:10.29238/teknolabjournal.v10i2.307
COVID-19 infection and liver damage in children. Clinical case study.
Liubarscaia, S., Raba, T., Ciobanu, L., Chiosea, L., & Tihai, O. (2022) · Moldovan Journal of Health Sciences · doi:10.52645/mjhs.2022.2.11
Hepatotoxicidad por metilprednisolona. Reporte de un caso
Duarte, V., Taborda, A., de León, Y., & Facal, J. (2022) · Revista Médica del Uruguay · doi:10.29193/rmu.38.2.9
Review of Liver Enzymes Abnormalities in Patients with SARS-CoV-2 Infection
Tameemi, W. F. A., & Al-Sharqi, A. H. M. M. (2022) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20221001.11
Dividis, G., Papadopoulos, G. E., Karageorgiou, I., & Kotronis, G. (2022) · Cureus · doi:10.7759/cureus.32353
Trapeznikova, E. G., & Шилов, В. В. (2022) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2022-62-11-761-766
Hepatic Injury from Chemotherapy
Rubbia‐Brandt, L. (2022) · Springer eBooks · doi:10.1007/978-3-031-09323-4_44
Intensivtherapie bei akutem und chronischem Leberversagen
Sarrazin, C., Schneider, M., Bechstein, W. O., & Zeuzem, S. (2022) · Springer Reference Medizin · doi:10.1007/978-3-642-54675-4_74-2
Gárate‐Rascón, M. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/65009
Сыраева, Г. И., Vasilyuk, V. B., Verveda, A. B., Фарапонова, М. В., Колбин, А. С., & Borovskaya, V. G. (2023) · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · doi:10.37489/2588-0519-2022-4-73-82
Chung, W. K., Gu, H. J., Yoon, J. Y., & Kang, J. S. (2023) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2023.40.1.004
Leberfunktionsstörungen bei geriatrischen Patienten
Kasper, P., Tacke, F., Heppner, H. J., & Michels, G. (2023) · Die Gastroenterologie · doi:10.1007/s11377-023-00686-3
Прокопчук, О. В. (2023) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2023.v.i1.13730
Medikamentös-toxische Hepatopathie – eine unterschätzte Gefahr
Roeb, E. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1871-6426
Analysis of Serum Cytokines in Antituberculosis Drug-Induced Liver Injury
刘, 慧. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361434
DAÑO HEPÁTICO INDUCIDO POR MEDICAMENTOS
Valdes, E. A., Salehji, A., & Demera, A. (2022) · Revista Médico Científica · doi:10.37416/rmc.v35i1.740
The current state of the problem of drug hepatotoxicity and measures of its prevention and treatment
Shmanko, V. V., Shmanko, O. V., & Лазарчук, Т. Б. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.30.01.010
de la Osa, D. R., de Castro, E. G., Argeñal, L. F. A., Urra, C. P., Román, M. C., Citores, L. P., Moretón, Á. M. M., Allúe, L. L., & Millán, A. G. P. (2023) · Revista Andaluza de Patología Digestiva · doi:10.37352/2023464.1
Nitroimidazole Derivative Antimicrobial Drugs and Liver Injury
Balaban, U., İnkaya, A. Ç., & Kara, E. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20237538
Liver Oncologic Surgical Emergencies
Schellenberg, M. A., Nanji, S. A., Raphael, M. J., & Ball, C. G. (2023) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-031-36860-8_12
Sakellariou, S. (2023) · Open Journal of Clinical and Medical Case Reports · doi:10.52768/2379-1039/2005
Zheng, H., Zhou, K., Zheng, Z., Xiao, M., Wen, F., Wu, F., & Wu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3441315/v1
Etiology and Diagnosis and Treatment of Markedly Elevated Transaminases
谢, 晓. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13102352
Practical Approach to Abnormal Liver Enzymes in Patients with Inflammatory Bowel Disease
Marco, D. D., & Benmassaoud, A. (2023) · Canadian IBD Today · doi:10.58931/cibdt.2023.1317
Xie, S., Chen, M., Qiu, L., Li, L., Deng, S., Liu, F., Fu, H., & Wang, Y. (2023) · Journal of Immunology Research · doi:10.1155/2023/6616822
Kumbara, C. I. Y. K., Purnamasidhi, . A. W., Mariadi, I. K., Somayana, G., Wibawa, I. D. N., & Indraswari, P. G. (2023) · Jurnal Penyakit Dalam Udayana · doi:10.36216/ptcah553
Tuberculosis with Drug-Induced Hepatitis: A Narrative Literature Review
Sari, R. Y., & Fauzi, Z. A. (2023) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v8i2.929
EFFECT OF VITAMIN D ON LIVER ENZYMES AND NAFLD
Fayaz, H., Iftikhar, A., Khan, J. U. A., Khalil, S. K., Razaq, S., & Aziz, Q. (2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/jptcp.v30i19.3631
Research Progress on Drug-Induced Liver Injury in the Elderly
谭, 辉. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122776
Clinical and laboratory diagnostics of drug-induced liver injury by antibiotics
Bereznyakova, M., Залюбовська, О. І., Bereznyakov, I. G., & Lytvynenko, M. (2023) · Medicine Today and Tomorrow · doi:10.35339/msz.2023.92.4.bzb
Kumbara, C. I. Y. K., Purnamasidhi, . A. W., Mariadi, I. K., Somayana, G., Wibawa, I. D. N., & Indraswari, P. G. (2023) · Jurnal Penyakit Dalam Udayana · doi:10.36216/jpd.v7i2.225
Eleiwa, N. Z. H., Khalifa, H. A., & Nazim, H. A. (2024) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2023-0385
Hemophilia and hepatology, back to the future
Olveira, A., & Jiménez‐Yuste, V. (2024) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2024.10105/2023
Bondarenko, O. O., & Maksymets, T. A. (2024) · Modern Gastroenterology · doi:10.30978/mg-2024-1-81
Gomes, L. D. S., Pereira, B. R. A., Dias, L. M. F., Mesquita, J. L., Passos, B. V. D. S., & Sousa, M. (2024) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2024.151.1020
Yang, T., Jia, Z., Xu, C., Chen, G., Xiang, L., & Li, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-4119283/v1
alhuzaym, Z. A., bujubarah, M. M. H., alzaher, A. N., Rashed, A. G. A. A., Alamri, A. A. M., Alzahrani, H. A. M., Alshihri, S. A., Alamer, A. A., alnajadi, Z. Y., Almuqadam, J. S. H., et al. (2022) · doi:10.53555//jptcp.v29i04.5575
Jüngst, C., & Kullak-Ublick, G. A. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21005-1.00051-2
Self-citationMedikamentös induzierte Leberschädigungen
Trautwein, C., & Elfers, C. (2024) · Gastroenterologie up2date · doi:10.1055/a-2024-7275
Corredor-Rengifo, D., Sanchez-Romero, M., Ocampo-Posada, M., & Gómez-Ramírez, D. M. (2024) · Hepatología · doi:10.59093/27112330.102
Lesión hepática inducida por Phyllanthus niruri (chancapiedra), un remedio natural para urolitiasis
Gómez-Jordan, S., Quevedo, M. D. M., Vergara-Barrios, P., & Marín, J. I. (2024) · Hepatología · doi:10.59093/27112330.103
Drug-induced liver injury in children
Ravikumar, B., Aithal, G. P., & Kelgeri, C. (2024) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2024-326853
Self-citation
Metadata
- Authors
- Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H.
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 70
- Issue
- 6
- Pages
- 1222-1261
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2924328881
- Semantic Scholar
- 6d774d1c570eef200451a1e8a8f5655c367a4eaf
- Cited by
- 1,276
- References
- 371
- Citations by year
- 2026: 243 · 2025: 211 · 2024: 175 · 2023: 159 · 2022: 158 · 2021: 184 · 2020: 117 · 2019: 27
- FWCI
- 78.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Cooperation in Science & Technology
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, idiosyncratic drug-induced liver injury, hepatotoxicity, acute liver failure, risk factors, diagnosis, risk minimization
- MeSH terms
- Adult, Aged, Fatty Liver, Female, Histocompatibility Testing, Humans, Liver Neoplasms, Male, Middle Aged, Mitochondria, Risk Factors, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
